[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Latin America, Middle East & Africa Pneumonia Vaccines Market (2019-2025)

June 2019 | 102 pages | ID: L78EFC11E5DEN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Latin America, Middle East and Africa Pneumonia Vaccines Market would witness market growth of 10.1% CAGR during the forecast period (2019–2025).

Pneumonia is a disease that causes lung contamination occurring in one or both the lungs caused by bacterial organisms, viruses, or fungi; bacterial pneumonia is the most common in adults. Pneumonia results in irritation around the ‘sacs’, also known as alveoli of the lungs, which causes the alveoli to fill with pus, resulting in breathing issues. PCV13 protects against the 13 kinds of pneumococcal bacteria which cause the most severe illness among children and adults. It is suggested for routine use among children that are 5 years or younger and adults 65 years of age and older. It is also suggested to help prevent pneumococcal disease in individuals through 64 years of age with medical conditions that place them at increased risk for pneumococcal disease. Development of protein-based combination pneumococcal vaccines is expected to offer lucrative opportunities for the expansion of this market during the forecast period.

Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.

Scope of the Study

Market Segmentation:

By Vaccine Type
  • Pneumococcal conjugate vaccine (PCV)
  • Pneumococcal polysaccharide vaccine (PPSV/PPV)
By Product Type
  • Prevnar 13
  • Synflorix
  • Pneumovax23
By Sector
  • Public sector
  • Private sector
By Distribution Channel
  • Distribution partner companies
  • Non-governmental Organizations (NGO)
  • Government Authorities
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Glaxosmithkline Plc. (GSK)
  • LG Corporation
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • Poonawalla Investments & Industries Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • SK Holdings Co., Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Merck & Co., Inc.
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 LAMEA Pneumonia Vaccines Market, by Vaccine Type
  1.4.2 LAMEA Pneumonia Vaccines Market, by Product Type
  1.4.3 LAMEA Pneumonia Vaccines Market, by Sector
  1.4.4 LAMEA Pneumonia Vaccines Market, by Distribution Channel
  1.4.5 LAMEA Pneumonia Vaccines Market, by Region
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE

3.1 LAMEA Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 LAMEA Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region

CHAPTER 4. LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE

4.1 LAMEA Prevnar 13 Market by Region
4.2 LAMEA Synflorix Market by Region
4.3 LAMEA Pneumovax 23 Market by Region

CHAPTER 5. LAMEA PNEUMONIA VACCINES MARKET BY SECTOR

5.1 LAMEA Private sector Market by Region
5.2 LAMEA Public sector Market by Region

CHAPTER 6. LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL

6.1 LAMEA Distribution Partner Companies Market by Region
6.2 LAMEA Non-Governmental Organizations (NGO) Market by Region
6.3 LAMEA Government Authorities Market by Region

CHAPTER 7. LAMEA PNEUMONIA VACCINES MARKET BY REGION

7.1 Brazil Pneumonia Vaccines Market
  7.1.1 Brazil Pneumonia Vaccines Market by Vaccine Type
  7.1.2 Brazil Pneumonia Vaccines Market by Product Type
  7.1.3 Brazil Pneumonia Vaccines Market by Sector
  7.1.4 Brazil Pneumonia Vaccines Market by Distribution Channel
7.2 Argentina Pneumonia Vaccines Market
  7.2.1 Argentina Pneumonia Vaccines Market by Vaccine Type
  7.2.2 Argentina Pneumonia Vaccines Market by Product Type
  7.2.3 Argentina Pneumonia Vaccines Market by Sector
  7.2.4 Argentina Pneumonia Vaccines Market by Distribution Channel
7.3 UAE Pneumonia Vaccines Market
  7.3.1 UAE Pneumonia Vaccines Market by Vaccine Type
  7.3.2 UAE Pneumonia Vaccines Market by Product Type
  7.3.3 UAE Pneumonia Vaccines Market by Sector
  7.3.4 UAE Pneumonia Vaccines Market by Distribution Channel
7.4 Saudi Arabia Pneumonia Vaccines Market
  7.4.1 Saudi Arabia Pneumonia Vaccines Market by Vaccine Type
  7.4.2 Saudi Arabia Pneumonia Vaccines Market by Product Type
  7.4.3 Saudi Arabia Pneumonia Vaccines Market by Sector
  7.4.4 Saudi Arabia Pneumonia Vaccines Market by Distribution Channel
7.5 South Africa Pneumonia Vaccines Market
  7.5.1 South Africa Pneumonia Vaccines Market by Vaccine Type
  7.5.2 South Africa Pneumonia Vaccines Market by Product Type
  7.5.3 South Africa Pneumonia Vaccines Market by Sector
  7.5.4 South Africa Pneumonia Vaccines Market by Distribution Channel
7.6 Nigeria Pneumonia Vaccines Market
  7.6.1 Nigeria Pneumonia Vaccines Market by Vaccine Type
  7.6.2 Nigeria Pneumonia Vaccines Market by Product Type
  7.6.3 Nigeria Pneumonia Vaccines Market by Sector
  7.6.4 Nigeria Pneumonia Vaccines Market by Distribution Channel
7.7 Rest of LAMEA Pneumonia Vaccines Market
  7.7.1 Rest of LAMEA Pneumonia Vaccines Market by Vaccine Type
  7.7.2 Rest of LAMEA Pneumonia Vaccines Market by Product Type
  7.7.3 Rest of LAMEA Pneumonia Vaccines Market by Sector
  7.7.4 Rest of LAMEA Pneumonia Vaccines Market by Distribution Channel

CHAPTER 8. COMPANY PROFILES

8.1 GLAXOSMITHKLINE PLC (GSK)
  8.1.1 Company Overview
  8.1.2 Financial Analysis
  8.1.3 Segmental and Regional Analysis
  8.1.4 Research & Development Expense
  8.1.1 Recent strategies and developments:
    8.1.1.1 Collaboration, partnerships and agreements:
    8.1.1.2 Expansion:
  8.1.2 SWOT Analysis
8.2 LG Corporation (LG Chemicals Ltd.)
  8.2.1 Company Overview
  8.2.2 Financial Analysis
  8.2.3 Segmental and Regional Analysis
  8.2.4 Research & Development Expense
  8.2.5 SWOT Analysis
8.3 Panacea Biotec Limited
  8.3.1 Company Overview
  8.3.2 Financial Analysis
  8.3.3 Segmental and Regional Analysis
  8.3.4 Research & Development Expense
  8.3.5 Recent strategies and developments:
    8.3.5.1 Collaboration, partnerships and agreements:
  8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
  8.4.1 Company Overview
  8.4.2 Financial Analysis
  8.4.3 Segmental and Regional Analysis
  8.4.4 Research & Development Expense
  8.4.5 Recent strategies and developments:
    8.4.5.1 Collaboration, partnerships and agreements:
    8.4.5.2 Product launch:
  8.4.6 SWOT Analysis
8.5 PnuVax Incorporated
  8.5.1 Company Overview
8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
  8.6.1 Company Overview
8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
  8.7.1 Company Overview
8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
  8.8.1 Company overview
  8.8.2 Financial Analysis
  8.8.3 Segmental and Regional Analysis
  8.8.4 Research & Development Expenses
8.9 Walvax Biotechnology Co., Ltd.
  8.9.1 Company Overview
  8.9.2 Recent strategies and developments:
    8.9.2.1 Product launch:
8.1 Merck & Co., Inc.
  8.10.1 Company Overview
  8.10.2 Financial Analysis
  8.10.3 Segmental and Regional Analysis
  8.10.4 Research & Development Expenses
  8.10.5 Recent strategies and developments:
    8.10.5.1 Collaboration, partnerships and agreements:
    8.10.5.2 Product launch:
  8.10.6 SWOT Analysis

LIST OF TABLES

TABLE 1 LAMEA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 3 LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 4 LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 5 LAMEA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 LAMEA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 LAMEA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 LAMEA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 10 LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 11 LAMEA PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 LAMEA PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 LAMEA SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 LAMEA SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 LAMEA PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 16 LAMEA PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 17 LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 18 LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 19 LAMEA PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 LAMEA PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 LAMEA PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 LAMEA PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 LAMEA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 LAMEA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 LAMEA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 28 LAMEA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 29 LAMEA GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 LAMEA GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 LAMEA PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 LAMEA PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 BRAZIL PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 34 BRAZIL PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 35 BRAZIL PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 36 BRAZIL PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 37 BRAZIL PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 38 BRAZIL PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 39 BRAZIL PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 40 BRAZIL PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 41 BRAZIL PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 BRAZIL PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 ARGENTINA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 44 ARGENTINA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 45 ARGENTINA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 46 ARGENTINA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 47 ARGENTINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 48 ARGENTINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 49 ARGENTINA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 50 ARGENTINA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 51 ARGENTINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 ARGENTINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 UAE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 54 UAE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 55 UAE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 56 UAE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 57 UAE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 58 UAE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 59 UAE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 60 UAE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 61 UAE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 62 UAE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 63 SAUDI ARABIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 64 SAUDI ARABIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 65 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 66 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 67 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 68 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 69 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 70 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 71 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 72 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 73 SOUTH AFRICA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 74 SOUTH AFRICA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 75 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 76 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 77 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 78 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 79 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 80 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 81 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 NIGERIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 84 NIGERIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 85 NIGERIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 86 NIGERIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 87 NIGERIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 88 NIGERIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 89 NIGERIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 90 NIGERIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 91 NIGERIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 NIGERIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 REST OF LAMEA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 94 REST OF LAMEA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
TABLE 95 REST OF LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 96 REST OF LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 97 REST OF LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 98 REST OF LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 99 REST OF LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 100 REST OF LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 101 REST OF LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 102 REST OF LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 103 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 104 KEY INFORMATION – LG CORPORATION
TABLE 105 KEY INFORMATION – PANACEA BIOTEC LIMITED
TABLE 106 KEY INFORMATION – PFIZER, INC.
TABLE 107 KEY INFORMATION – PNUVAX INCORPORATED
TABLE 108 KEY INFORMATION – POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
TABLE 109 KEY INFORMATION – SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
TABLE 110 KEY INFORMATION – SK HOLDINGS CO., LTD.
TABLE 111 KEY INFORMATION – WALVAX BIOTECHNOLOGY CO., LTD.
TABLE 112 KEY INFORMATION - MERCK & CO., INC.

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH


More Publications